The importance of age, fludarabine, and total body irradiation in the incidence and severity of chronic renal failure after allogeneic hematopoietic cell transplantation

被引:31
作者
Delgado, J
Cooper, N
Thomson, K
Duarte, R
Jarmulowicz, M
Cassoni, A
Kortaridis, P
Peggs, K
Mackinnon, S
机构
[1] UCL Royal Free & Univ Coll, Sch Med, Dept Hematol, London, England
[2] UCL Royal Free & Univ Coll, Sch Med, Dept Histopathol, London, England
[3] UCL Royal Free & Univ Coll, Sch Med, Dept Clin Oncol, London, England
关键词
renal failure; total body irradiation; fludarabine; hematopoletic cell transplantation;
D O I
10.1016/j.bbmt.2005.08.036
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Nonmalignant late effects, including chronic renal failure (CRF), impair the quality of life of long-term survivors after allogeneic hematopoietic cell transplantation. One of the major risk factors is the use of total body irradiation (TBI) in the preparative regimen; TBI is currently fractionated in an attempt to reduce toxicity. We analyzed 241 patients who had TBI-based preparative regimens for allogeneic hematopoietic cell transplantation. TBI was delivered as a single fraction of 7.5 Gy (7.5S group), 12 Gy in 6 fractions (12F group), or 14.4 Gy in 8 fractions (14.4F group). The cumulative incidence of CRF at 2 years was 12%. Statistical analysis revealed that older age (P < .001) and fludarabine administration (P =.016) had a significant effect on the incidence of CRF. Furthermore, single-fraction TBI was also significantly associated with CPF severity, because 7 (6.3%) of 111 patients in the 7.5S group developed severe CRF, as opposed to 1 (0.8%) of 130 patients in the 12F and 14.4F groups combined (P =.044). However, these conclusions should be regarded as preliminary in view of the retrospective and nonrandomized nature of this studv. (c) 2006 American Society for Blood and Marrow Transplantation.
引用
收藏
页码:75 / 83
页数:9
相关论文
共 45 条
[1]   DELAYED RENAL-FAILURE WITH EXTENSIVE MESANGIOLYSIS FOLLOWING BONE-MARROW TRANSPLANTATION [J].
ANTIGNAC, C ;
GUBLER, MC ;
LEVERGER, G ;
BROYER, M ;
HABIB, R ;
LACOSTE, M ;
BEZIAU, A ;
NAIZOT, C .
KIDNEY INTERNATIONAL, 1989, 35 (06) :1336-1344
[2]   Renal toxicity after total body irradiation [J].
Borg, M ;
Hughes, T ;
Horvath, N ;
Rice, M ;
Thomas, AC .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2002, 54 (04) :1165-1173
[3]  
BORGSTROM B, 1994, BONE MARROW TRANSPL, V13, P59
[4]   Renal transplantation for end-stage renal disease following bone marrow transplantation: A report of six cases, with and without immunosuppression [J].
Butcher, JA ;
Hariharan, S ;
Adams, MB ;
Johnson, CP ;
Roza, AM ;
Cohen, EP .
CLINICAL TRANSPLANTATION, 1999, 13 (04) :330-335
[5]  
CHAPPELL ME, 1988, BONE MARROW TRANSPL, V3, P339
[6]   Toxicities of total-body irradiation for pediatric bone marrow transplantation [J].
Chou, RH ;
Wong, GB ;
Kramer, JH ;
Wara, DW ;
Matthay, KK ;
Crittenden, MR ;
Swift, PS ;
Cowan, MJ ;
Wara, WM .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1996, 34 (04) :843-851
[7]  
COGAN MG, 1978, CLIN NEPHROL, V10, P74
[8]   Radiation nephropathy after bone marrow transplantation [J].
Cohen, EP .
KIDNEY INTERNATIONAL, 2000, 58 (02) :903-918
[9]   Renal failure after bone-marrow transplantation [J].
Cohen, EP .
LANCET, 2001, 357 (9249) :6-7
[10]   Solid cancers after bone marrow transplantation [J].
Curtis, RE ;
Rowlings, PA ;
Deeg, HJ ;
Shriner, DA ;
Socie, G ;
Travis, LB ;
Horowitz, MM ;
Witherspoon, RP ;
Hoover, RN ;
Sobocinski, KA ;
Fraumeni, JF ;
Boice, JD .
NEW ENGLAND JOURNAL OF MEDICINE, 1997, 336 (13) :897-904